SYRACUSE, NEW YORK / ACCESS Newswire / May 19, 2025 / Repair Biotechnologies, Inc. ( is a biotechnology company developing first-in-class therapies capable of rapidly reducing atherosclerotic plaque.

Robert F. Kennedy Jr. clinched the political support needed to become the nation's top health official by pledging to work ...

The FDA deemed the recall a Class II, meaning ingesting a product might cause temporary or medically reversible adverse ...

By Kamal Choudhury (Reuters) -Novavax shares jumped more than 15% on Monday after the company secured a long-awaited U.S.

Jivi first received FDA approval in August 2018. The approval was for use in previously treated adults aged 12 and older who have hemophilia A. The uses included on-demand treatment and control of ...

Apnimed will be waiting for the readout from a second Phase III trial before it approaches the FDA with an NDA for the sleep apnoea pill.

During a call with U.S. doctors this month, one CDC official noted that there is a seasonality to bird flu: Cases peak in the ...

SILVER SPRING, MD. — The US Food and Drug Administration (FDA) and the National Institutes of Health (NIH) are launching the Nutrition Regulatory Science Program (NRSP), a joint research initiative to ...

Novavax Inc. jumped after US regulators fully approved its Covid vaccine, easing investors’ concerns after the clearance was ...

Novavax had expected full approval for broader use by April 1, after the FDA reviewed data from a 30,000-person clinical ...

EndoQuest Robotics completed two procedures with its endoluminal system, while Virtuoso Surgical successfully performed ...

What happened to 23andMe? Here's a look at its history from launch to bankruptcy and acquisition by Regeneron.